BioSpace News Archive

Animal Dermatology Clinic Marina Del Rey announces Dr. Austin Richman has achieved Diplomate status with the American College of Veterinary Dermatology (ACVD).

Beleave Inc. (CSE: BE) (OTCQX: BLEVF) (“Beleave” or the “Company”) announces that its second quarter 2018 results will be released after market on Thursday, November 29, 2018 and will be followed by the Company’s first ever conference call on Friday, November 30, 2018 at 11:00 a.m.

MedX Health Corp. (“MedX” or the “Company”) (TSX-V:MDX) announces that, pursuant to a non-brokered Private Placement Offering (the “Placement Offering”), it has completed an additional Closing of 1,137,500 Units on November 22, 2018, to raise $182,000 from accredited investors pursuant to a Private Placement Offering originally announced on October 11, 2018.

Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, reaffirms the company’s vision on addressing the diagnostic imaging needs of today and tomorrow.

Future-focused breast health leader will highlight recent advancements with interactive booth experiences, workshops and symposia

Autolus Therapeutics plc today announced that it has filed its annual report on Form 20-F for the fiscal year ended 2018 with the United States Securities and Exchange Commission.

SpendEdge, a global procurement market intelligence firm, has announced the release of their Global Tablet Coatings Category - Procurement Market Intelligence Report.

The International Alliance of Carer Organizations (IACO) is releasing a landmark report “The Global State of Care” at the International Forum on Care and Caregiving: Research, Policy and Practice in Toronto, Canada.

Tandigm Health (Tandigm), a value-based healthcare company that supports health plans by collaborating with primary care physicians to enhance and improve patient care, announced today that it is sending letters to patients about a recent security incident involving patient information.

Indivior PLC (LON: INDV) today announced that Health Canada has approved SUBLOCADETM (buprenorphine extended-release) injection for subcutaneous use, for the management of moderate to severe opioid use disorder (OUD) in adult patients